Stockreport

XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybi...

XTL Biopharmaceuticals Ltd. - American Depositary Shares  (XTLB) 
US:NASDAQ Investor Relations: xtlbio.com
PDF Transaction Positions XTL at the Forefront of the Rapidly Expanding Global Psychedelic Therapeutics Market Following Major U.S. Regulatory Momentum Seven Approved Phase [Read more]